NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 46 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2017. The put-call ratio across all filers is 4.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $48,000 | -96.7% | 30,494 | -95.3% | 0.00% | – |
| Q1 2021 | $1,455,000 | -3.0% | 655,393 | +8.3% | 0.00% | – |
| Q4 2020 | $1,500,000 | +23.0% | 605,015 | +21.9% | 0.00% | – |
| Q3 2020 | $1,220,000 | -18.6% | 496,121 | +17.6% | 0.00% | – |
| Q2 2020 | $1,498,000 | +4305.9% | 421,983 | +1682.2% | 0.00% | – |
| Q2 2019 | $34,000 | -96.4% | 23,677 | -95.1% | 0.00% | – |
| Q1 2019 | $957,000 | +56.6% | 485,584 | +4.0% | 0.00% | – |
| Q4 2018 | $611,000 | -48.2% | 466,747 | -2.8% | 0.00% | – |
| Q3 2018 | $1,180,000 | -26.2% | 480,363 | +0.9% | 0.00% | – |
| Q2 2018 | $1,599,000 | -17.0% | 476,234 | +4.5% | 0.00% | – |
| Q1 2018 | $1,927,000 | +53.1% | 455,613 | +19.4% | 0.00% | – |
| Q4 2017 | $1,259,000 | +1.0% | 381,582 | +17.1% | 0.00% | – |
| Q3 2017 | $1,246,000 | -5.8% | 325,887 | +8.3% | 0.00% | – |
| Q2 2017 | $1,323,000 | – | 300,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Citizens Financial Corp | 35,100 | $82,000 | 0.11% |
| Patriot Financial Group Insurance Agency, LLC | 71,060 | $166,000 | 0.08% |
| Willow Creek Wealth Management Inc. | 24,224 | $57,000 | 0.03% |
| WEBSTER BANK, N. A. | 60,000 | $140,000 | 0.02% |
| HighPoint Advisor Group LLC | 34,000 | $98,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $60,000 | 0.02% |
| WMS Partners, LLC | 18,000 | $42,000 | 0.01% |
| WEDBUSH SECURITIES INC | 33,900 | $79,000 | 0.01% |
| ExodusPoint Capital Management, LP | 56,618 | $132,000 | 0.01% |
| Qube Research & Technologies Ltd | 66,800 | $156,000 | 0.01% |